news roundup
Veeva Systems announced the agreement to acquire Crossix Solutions, which delivers privacy-safe US patient data and an analytics platform to help maximize media and marketing effectiveness.
| advertisement
Exclusive Video from DIA:
Overcoming Complex Challenges: Identifying eCOA and IRT Trends
 Watch Video
|
SCDM's “The Evolution of Clinical Data Management to Data Science” highlights rising complexity of clinical research approaches, AI and wearables, and data science career considerations as part of the future of CDM.
| advertisement
Launching Medical Devices in the Japanese Market - How to navigate regulatory and reimbursement approval
Thursday, October 31, 2019 at 11am EDT
 Register Now |
|
|
|
|
Advertisement
In this edition
|
|
Subscribe
 |
Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers » |
|
|
|
IQVIA is collaborating with Friends of Cancer Research in a cross-industry effort to advance acceptance and drive future uses of real-world evidence (RWE) in oncology research.
| advertisement
Will Decentralized Clinical Trials Compound Patient and Data Quality Risks?
Tuesday, October 29, 2019 at 1pm EDT | 12pm CDT| 10am PDT
 Register Now |
Articles
In this interview, Charlotte Jones-Burton, MD, executive director and the cardiovascular development team lead, innovative medicines, at Bristol-Myers Squibb, discusses the importance of diversifying clinical trials for better patient outcomes.
| advertisement
GrantPlan: Create Grant Budgets with Confidence and Accuracy
Thursday, October 10, 2019 at 11am EDT
 Register Now |
A recent industry roundtable comprised of experts from across academia, sites, CROs, and sponsors convened to discuss opportunities to improve information exchange in clinical trials, the potential for technology to advance collaboration, and practical steps to impact positive change.
| advertisement
Begin with the End in Mind: The Strategic Benefit of Coordinating Site Budgeting, Contracting, & Payments
Wednesday, October 2, 2019 at 11am EDT
 Register Now |
|
|
|
| advertisement
How AI/ML and advanced techniques are enhancing clinical development
Lessons learned from use in study design, patient and site ID, safety, and risk-based monitoring
Tuesday, October 1, 2019 at 11am EDT
 Register Now |
Blog Posts
In this interview, Ralph Kern, COO and CMO of BrainStorm, discusses how his company addresses the challenges of trials and advancing science in neurodegenerative disease.
| advertisement
Successful Early Phase Drug Development of mAb Drugs
 On Demand |
Brussels Correspondent Peter O'Donnell reports that UK socialists have raised the drug pricing and patient access arguments with a strongly-worded plan for reining-in profit-driven drug firms.
|
|
|
|
|
Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription |
|
|
|
|
|
